Influence of Two Different Preloaded Intraocular Lens (IOLs) on Posterior Capsule Opacification
NCT ID: NCT00673803
Last Updated: 2010-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
40 participants
INTERVENTIONAL
2008-12-31
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Progression in cataract surgery technique allow phacoemulsification through micro-incisions. Therefore there is need for IOLs that can be implanted through incisions of about 2.5 mm.
This study investigates the effect of two different hydrophobic acrylic IOLs with a sharp posterior optic edge on the rate of PCO after implantation through a micro-incision. The results will be compared intraindividually.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Posterior Capsule Opacification and Optical Quality of Different Hydrophobic Acrylic Intraocular Lenses
NCT03831074
Effect of Optic Edge Design in a Silicone Intraocular Lens on Posterior Capsule Opacification
NCT00428363
Comparison of the Effect of Hydrophobic Acrylic and Silicone 3-piece IOLs on Posterior Capsule Opacification
NCT01936701
Posterior Capsule Opacification and Frequency of Nd:YAG Treatment and of Two Microincision IOLs: Hoya iMics NY-60 vs Acrysof SN60WF
NCT01732484
Posterior Capsule Opacification Development With Two Different Intraocular Lenses
NCT01734343
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
PCO rate will be detected at 1 year and 2 years.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
cataract surgery, implantation of a Polylens Y10
cataract surgery
cataract surgery with implantation of an IOL
B
cataract surgery, implantation of a Polylens Y30
cataract surgery
cataract surgery with implantation of an IOL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cataract surgery
cataract surgery with implantation of an IOL
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 55 to 80 years
* expected postoperative visual acuity of at least 0.5
Exclusion Criteria
* corneal scars
* diabetes
* pseudoexfoliation-syndrome
* earlier ocular surgeries or laser treatments
* intraocular tumors
55 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Hietzing
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hietzing Hospital, Vienna, Austria
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nadja Karnik, MD
Role: STUDY_CHAIR
Dept of Ophthalmology, Hietzing Hospital, Vienna, Austria
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Ophthalmology, Hietzing Hospital
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
preloaded 2008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.